Cargando…

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

BACKGROUND & AIMS: A recent consensus document has defined metabolic dysfunction-associated fatty liver disease (MAFLD) as hepatic steatosis together with overweight, diabetes, and/or a combination of other metabolic risk factors. The clinical relevance of this novel diagnosis is unknown among p...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kleef, Laurens A., Choi, Hannah S.J., Brouwer, Willem P., Hansen, Bettina E., Patel, Keyur, de Man, Robert A., Janssen, Harry L.A., de Knegt, Robert J., Sonneveld, Milan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446794/
https://www.ncbi.nlm.nih.gov/pubmed/34557660
http://dx.doi.org/10.1016/j.jhepr.2021.100350